Clinical Trial Update: The Intra-Drug Eluting Stent (DES) Restenosis Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the Intra-Drug Eluting Stent for coronary artery disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Intra-Drug Eluting Stent

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED